Aashka Shah, Vidhi Solanki* and Dipal Patel
Department of Ophthalmology, Gujarat University, India
*Corresponding Author:Vidhi Solanki, Department of Ophthalmology, Gujarat University, India.
Received: September 23, 2020; Published: October 16, 2020
Aim: To find out the efficacy of macular photocoagulation when given in the early or late period after single intravitreal bevacizumab injection in terms of central foveal thickness change and visual acuity gain.
Methods: 40 patient eyes were studied and they were divided into groups based on sex, age, hba1c levels, severity of disease and treatment received over the period of 6 months.
Result and Conclusion: Patients receiving deferred macular photocoagulation after a single intravitreal injection of bevacizumab had better outcomes regarding reduction of central foveal thickness and improvement in visual acuity at the end of 6 month observation period compared to those patients receiving prompt macular photocoagulation.
Keywords: Bevacizumab; Laser Photocoagulation; Diabetic Retinopathy; Central Foveal Thickness; Clinically Significant Macular Edema
Citation: Vidhi Solanki., et al. “To Study the Effect on Central Foveal Thickness Following Prompt/Deferred Macular Photocoagulation After Single Intravitreal Bevacizumab Injection". Acta Scientific Ophthalmology 3.11 (2020): 27-32.
Copyright: © 2020 Vidhi Solanki., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.